Several GST inhibitors have been developed to overcome drug resistance in cancer therapy. By inhibiting GST activity, these agents enhance the effectiveness of chemotherapy drugs. For instance, ethacrynic acid and TLK199 are known GST inhibitors that have shown promise in preclinical studies. Combining GST inhibitors with standard chemotherapy could improve treatment outcomes.
